Aida Pharmaceuticals, Inc.
AIDA · OTC
9/30/2008 | 6/30/2008 | 3/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Revenue | $11,885 | $10,900 | $7,652 | $10,517 |
| % Growth | 9% | 42.4% | -27.2% | – |
| Cost of Goods Sold | $4,958 | $4,732 | $3,700 | $4,770 |
| Gross Profit | $6,927 | $6,168 | $3,952 | $5,747 |
| % Margin | 58.3% | 56.6% | 51.6% | 54.6% |
| R&D Expenses | $326 | $354 | $283 | $46 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4,070 | $12,288 | $2,985 | $2,441 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$12,949 | $0 | $0 |
| Operating Expenses | $4,396 | -$306 | $3,268 | $2,487 |
| Operating Income | $2,531 | $6,474 | $684 | $3,260 |
| % Margin | 21.3% | 59.4% | 8.9% | 31% |
| Other Income/Exp. Net | -$592 | -$13,647 | -$371 | -$2,325 |
| Pre-Tax Income | $1,939 | -$7,173 | $313 | $934 |
| Tax Expense | -$936 | -$468 | $116 | $169 |
| Net Income | $2,290 | -$6,771 | -$19 | $2,406 |
| % Margin | 19.3% | -62.1% | -0.2% | 22.9% |
| EPS | 0.08 | -0.25 | -0.001 | 0.09 |
| % Growth | 132% | -35,614.3% | -100.8% | – |
| EPS Diluted | 0.08 | -0.25 | -0.001 | 0.09 |
| Weighted Avg Shares Out | 27,000 | 27,000 | 27,000 | 27,000 |
| Weighted Avg Shares Out Dil | 27,000 | 27,000 | 27,000 | 27,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $581 | $738 | $546 | $841 |
| Depreciation & Amortization | $825 | $683 | $501 | $463 |
| EBITDA | $3,356 | -$5,791 | $1,186 | $3,722 |
| % Margin | 28.2% | -53.1% | 15.5% | 35.4% |